Ameen Ghannam
-
- Chemokine receptors and signaling 5
- Peptidase Inhibition and Analysis 2
- Organic Chemistry top 10%
- Synthetic Organic Chemistry Methods 2
- Asymmetric Synthesis and Catalysis 2
- Chemical Synthesis and Reactions 2
-
- Monoclonal and Polyclonal Antibodies Research 3
-
- Aldose Reductase and Taurine 2
-
- Pharmacological Effects of Natural Compounds 2
- Co-authors
- Russell J. LindermanR. Michael SniderMeina LiangHoward P. NgRichard HorukJoseph HesselgesserImadul IslamMichael M. Morrissey
- Cited by
- OncologyImmunologyOrganic Chemistry
- Journals
- Journal of the American Chemical Society (2 papers)Journal of Biological Chemistry (1 paper)Circulation (1 paper)
- Partner nations
- United StatesMexicoUnited Kingdom
In The Last Decade
Ameen Ghannam
17 papers receiving 484 citations
Peers
Comparison fields: 5 of 65
- Oncology 210
- Immunology 160
- Organic Chemistry 158
- Endocrinology, Diabetes and Metabolism 71
- Transplantation 11
Countries citing papers authored by Ameen Ghannam
This map shows the geographic impact of Ameen Ghannam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ameen Ghannam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ameen Ghannam more than expected).
Fields of papers citing papers by Ameen Ghannam
This network shows the impact of papers produced by Ameen Ghannam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ameen Ghannam. The network helps show where Ameen Ghannam may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ameen Ghannam, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 2 | |
| 2 | 2020 | 5 | |
| 3 | Abstract 12904: Assessing Low-Density Lipoprotein Cholesterol Risk in Secondary Prevention Patients Within The PINNACLE National Outpatient Registry | 2019 | 8 |
| 4 | 2018 | 24 | |
| 5 | 2016 | 62 | |
| 6 | 2003 | 18 | |
| 7 | 2002 | 1 | |
| 8 | 2001 | 64 | |
| 9 | 2000 | 41 | |
| 10 | 1999 | 44 | |
| 11 | 1998 | 106 | |
| 12 | Hesselgesser, J. et al. Identification and characterization of small molecule functional antagonists of the CCR1 chemokine receptor. J. Biol. Chem. 273, 15687-15692 | 1998 | 1 |
| 13 | 1994 | 6 | |
| 14 | 1991 | 16 | |
| 15 | 1990 | 24 | |
| 16 | 1990 | 87 | |
| 17 | 1988 | 13 |
About Ameen Ghannam
Ameen Ghannam is a scholar working on Transplantation, Pharmaceutical Science and Oncology, having authored 17 papers that have together received 522 indexed citations. Recurring topics across this work include Chemokine receptors and signaling (5 papers), Monoclonal and Polyclonal Antibodies Research (3 papers), Aldose Reductase and Taurine (2 papers), Synthetic Organic Chemistry Methods (2 papers), Asymmetric Synthesis and Catalysis (2 papers), Peptidase Inhibition and Analysis (2 papers), Pharmacological Effects of Natural Compounds (2 papers) and Chemical Synthesis and Reactions (2 papers). The work is most often cited by research in Oncology (210 citations), Immunology (160 citations) and Organic Chemistry (158 citations). Ameen Ghannam has collaborated with scholars based in United States, Mexico and United Kingdom. Frequent co-authors include Russell J. Linderman, R. Michael Snider, Meina Liang, Howard P. Ng, Richard Horuk, Joseph Hesselgesser, Imadul Islam, Michael M. Morrissey, Karen May and John G. Bauman. Their work appears in journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and Circulation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.